Publication | Closed Access

Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer

MedicineImmunologyVirologyRecurrent Ovarian CancerReplicative AdenovirusOncologyRadiation OncologySafety ProfileViral OncologyOvarian CancerCancer-associated Virus